Navigating annual heartworm prevention requires precise administration, particularly when dealing with extended-release injectables like ProHeart 12. If you're a veterinary professional or a dog owner looking to understand how weight calculations translate into exact subcutaneous doses, getting the math right is non-negotiable. ProHeart 12 contains moxidectin and is approved exclusively for dogs aged 12 months and older. It provides a full year of continuous protection against Dirofilaria immitis, eliminating the margin for human error associated with monthly pills.
The core calculation relies on a strict metric baseline: 0.05 mL of the constituted suspension per kilogram of body weight (or roughly 0.023 mL per pound). Because weight fluctuations directly impact drug efficacy and safety, you shouldn't guess or estimate. This guide breaks down the official dosing standards, preparation protocols, and answers critical questions about safety and transition planning.
Understanding the ProHeart 12 Dosing Formula
The fundamental dosing rule for ProHeart 12 is straightforward, but it requires careful conversion if you're working in pounds. The product delivers 0.5 mg of moxidectin per kilogram of body weight.
To calculate the exact dose manually:
- Weigh the dog accurately on a calibrated scale at the time of treatment.
- Convert the weight from pounds to kilograms by dividing by 2.2.
- Multiply the weight in kilograms by 0.05 mL to find the total injection volume.
Example Calculation: For a 44 lb (20 kg) dog, multiply 20 kg by 0.05 mL. The required dose is exactly 1.00 mL.
Standard Weight-to-Volume Reference Guide
While individual weight calculations are always preferred, clinics use standard conversion benchmarks to speed up chairside preparation. Here is how weight tiers map to injection volumes:
- 11 lbs (5 kg): 0.25 mL
- 22 lbs (10 kg): 0.50 mL
- 33 lbs (15 kg): 0.75 mL
- 44 lbs (20 kg): 1.00 mL
- 55 lbs (25 kg): 1.25 mL
- 66 lbs (30 kg): 1.50 mL
- 77 lbs (35 kg): 1.75 mL
- 88 lbs (40 kg): 2.00 mL
- 99 lbs (45 kg): 2.25 mL
- 110 lbs (50 kg): 2.50 mL
- 121 lbs (55 kg): 2.75 mL
- 132 lbs (60 kg): 3.00 mL
If a dog's calculated dose exceeds 3 mL, the injection must be split across multiple sites. No single site should receive more than 3 mL of the suspension.
Step-by-Step Preparation and Constitution Procedures
ProHeart 12 isn't supplied as a ready-to-use liquid; it arrives as microspheres that must be mixed with a sterile vehicle before administration. Improper mixing leads to uneven drug distribution and compromised protection.
- Pre-mixing setup: Remove the product from storage and allow the components to reach room temperature. The 10 mL kit includes a microsphere vial and a sterile vehicle vial.
- Extracting the vehicle: Shake the sterile vehicle vial, then use a sterile syringe with an 18G or 20G needle to withdraw 8 mL of the vehicle.
- Venting and transferring: Insert a 25G vent needle into the microsphere vial to relieve pressure. Slowly inject the 8 mL of sterile vehicle into the microsphere vial, then remove both needles.
- Vigorous shaking: Shake the microsphere vial vigorously until the mixture transforms into a uniform, hazy-to-milky suspension.
- Resting period: Let the constituted suspension sit undisturbed for at least 30 minutes so large air bubbles can dissipate.
- Storage and stability: Once mixed, the suspension remains stable for up to 8 weeks if kept refrigerated. Always swirl the vial gently before drawing up subsequent doses to ensure the microspheres haven't settled.
For official safety guidelines and prescribing details, consult the FDA Animal Drugs database entry for ProHeart 12.
Administration Technique and Injection Protocols
Subcutaneous placement requires adherence to strict aseptic techniques to minimize local tissue irritation.
- Needle selection: Draw the calculated dose using a 1 mL or 3 mL syringe fitted with an 18G or 20G needle. Administer the dose promptly after drawing. If administration is delayed, roll the syringe gently to maintain suspension uniformity.
- Site selection: Inject subcutaneously into the left or right side of the dorsum of the neck, cranial to the scapula.
- Site rotation: Document which side receives the injection. Alternate sides during subsequent annual visits to prevent localized tissue reactions from repeating in the exact same spot.
Common Mistakes to Avoid
Precision matters immensely when dealing with sustained-release pharmacology. Veterinary teams and pet owners should watch out for these pitfalls:
- Underdosing growing dogs: Never dose a young, growing dog based on their expected adult weight. Always calculate the dose using their exact scale weight on the day of the injection.
- Skipping the resting period: Administering the suspension immediately after mixing without waiting 30 minutes can trap air bubbles in the syringe, distorting the delivered volume.
- Ignoring the transition window: When switching a dog from a monthly oral preventative to ProHeart 12, the injection must be given within one month of the last monthly dose to prevent a gap in coverage.
- Intramuscular or intravenous injection: ProHeart 12 is strictly formulated for subcutaneous use. Injected into muscle or blood vessels, the sustained-release mechanism fails.
To explore broader parasite control strategies, review the Companion Animal Parasite Council guidelines for up-to-date regional prevalence data and screening recommendations.
Frequently Asked Questions
Can ProHeart 12 be used in cats?
No. ProHeart 12 is explicitly labeled and formulated for use in dogs aged 12 months and older. It is not approved for cats, and administration to feline patients can cause severe adverse reactions.
What happens if a dog misses its annual 12-month window?
If more than 12 months have elapsed since the last injection, the dog is no longer protected. The veterinarian must perform a heartworm antigen and microfilariae test before administering a new dose. If the test is negative, a new injection can be given.
Is heartworm testing required before the first injection?
Yes. Dogs must be tested for existing heartworm infections prior to receiving ProHeart 12. If a dog is already infected with adult heartworms, those worms must be treated with an adulticide because ProHeart 12 only targets tissue larvae and hookworms, not mature adult heartworms.
Can ProHeart 12 be frozen during storage?
No. The unconstituted product should be stored at or below 25 degrees Celsius (77 degrees Fahrenheit) and protected from light. Once mixed, the suspension must be refrigerated and never frozen.
